SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)
ACCL 4.028+0.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tommysdad who wrote (9)6/6/1997 3:11:00 AM
From: Czechsinthemail   of 179
 
tommysdad,

Yes, PCOP is cheap here, but without news it will stay cheap.

One of the things I find exciting about this company is that they could announce news virtually anytime. The important need for a strong combinatorial partner will make continue to make attractive partnership opportunities (and with them the all-important cash flow) available to PCOP. This process should snowball as initial successes and announcements will lead to more deals being announced. Buying it here and socking it away puts you in a position to benefit from the stream of good news I think will be announced. Getting the company at the half-priced sale is a wonderful risk/reward opportunity, IMHO.

I expect PCOP will be a particular beneficiary of the race to exploit genomics information. Their combichem expertise should initially attract industry partners. And as they get a stronger cash flow position established, PCOP will be able to assume more research and development internally. But the efficiency their combinatorial chemistry can add to drug investigation and development makes the company a highly desirable partner or buyout possibility.

Too bad about no website. I guess it also means they're not likely to lurk and pick up the clue here.

Baird
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext